Analysts expect the Cambridge, Massachusetts-based company to report a quarterly loss at $2.68 per share, versus earnings of 55 cents per share in the year-ago period. Moderna projects quarterly ...

Retail Sales Retail Sales measure the change in the total value of sales at the retail level. It is the foremost indicator of ...

You’ve probably got one or two financial jobs on your to-do list that you were too busy to get to or perceived as boring administrative work ...

Whether you’re going back to college, sending a kid to school, a teacher making the classroom colorful and fun, or prepping ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

AS Inbank has approved the company's Financial Calendar for the 2025 financial year, according to which Inbank plans to disclose information and hold the Annual General Meeting of shareholders as ...

This strategic move is expected to provide a clearer alignment of FedEx (NYSE:FDX)'s financial reporting with the calendar year, which is standard practice for many corporations. The change may ...

aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today announces its indicative financial calendar for 2025. This ...

Founded in 2014 and based in Bournezeau (Vendée, Western France), Hoffmann Green Cement Technologies designs, produces and distributes innovative extremely low-carbon cements – with a carbon footprint ...

The Mid-year Financial Report for Illini West High School stated: “Overall, the district is in excellent financial condition.” The report was presented and approved by the Illini West board during its ...

Wells Fargo WFC-0.84%decrease; red down pointing triangle said Tuesday that its 2022 consent order with the Consumer Financial Protection Bureau relating to auto lending, consumer deposit accounts ...

Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with ...